방사선의학용 AI 시장 규모, 점유율 및 동향 분석 보고서 : 구성 요소별, 기술별, 모달리티별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

AI In Radiology Market Summary

The global AI in radiology market size was valued at USD 14.6 billion in 2025 and is projected to reach USD 193.0 billion by 2033, growing at a CAGR of 38.2% from 2026 to 2033. Rising demand for accurate, early disease detection, rapid growth in imaging volumes, and government initiatives and regulatory support are significant factors driving market growth.

In addition, the growing emphasis on cost-efficiency in healthcare delivery and technological advancements in machine learning, natural language processing, and computer vision are further fueling market growth. The section below outlines the key factors driving the growth of AI in the radiology market, highlighting rising demand for accurate and early disease detection, rapid technological advancements in AI and medical imaging, advancements in AI-driven clinical decision support and imaging solutions,supportive government initiatives, and regulatory frameworks, and increasing government funding and strategic research collaboration.

Global AI In Radiology Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global AI in radiology market report based on component, technology, modality, application, end use, and region.

• Component Outlook (Revenue, USD Million, 2021 - 2033)
• AI-enabled Devices
• Software & Platform
• Services
• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Machine Learning Algorithms
  • Deep learning
  • Supervised
  • Unsupervised
  • Others
• Natural Language Processing (NLP)
• Computer Vision Techniques
• Context-aware Computing
• Modality Outlook (Revenue, USD Million, 2021 - 2033)
• X-ray / Radiography
• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Ultrasound
• Mammography / Tomosynthesis
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Image Analysis
• Workflow Optimization
• Predictive Analytics
• Clinical Decision Support
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Clinics
• Diagnostic Imaging Centers
• Research and Academic Institutions
• Other
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Component Segment
  • 1.2.2. Technology Segment
  • 1.2.3. Modality Segment
  • 1.2.4. Application Segment
  • 1.2.5. End Use
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. AI in Radiology Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenges analysis
• 3.3. AI in Radiology Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
    • 3.3.2.4. Environmental Landscape
    • 3.3.2.5. Legal Landscape
    • 3.3.2.6. Social Landscape
• 3.4. Case Studies

Chapter 4. AI in Radiology Market: Component Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global AI in Radiology Market Component Movement Analysis
• 4.3. Global AI in Radiology Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
• 4.4. AI-enabled Devices
  • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.5. Software & Platform
  • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.6. Services
  • 4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. AI in Radiology Market: Technology Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global AI in Radiology Market Technology Movement Analysis
• 5.3. Global AI in Radiology Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
• 5.4. Machine Learning Algorithms
  • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.4.2. Deep learning
    • 5.4.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.4.3. Supervised
    • 5.4.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.4.4. Unsupervised
    • 5.4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.4.5. Others
    • 5.4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.5. Natural Language Processing (NLP)
  • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.6. Computer Vision Techniques
  • 5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.7. Context-aware Computing
  • 5.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. AI in Radiology Market: Modality Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global AI in Radiology Market Modality Movement Analysis
• 6.3. Global AI in Radiology Market Size & Trend Analysis, by Modality, 2021 to 2033 (USD Million)
• 6.4. X-ray / Radiography
  • 6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.5. Computed Tomography (CT)
  • 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.6. Magnetic Resonance Imaging (MRI)
  • 6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.7. Ultrasound
  • 6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.8. Mammography / Tomosynthesis
  • 6.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.9. Others
  • 6.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. AI in Radiology Market: Application Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global AI in Radiology Market Application Movement Analysis
• 7.3. Global AI in Radiology Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 7.4. Image Analysis
  • 7.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.5. Workflow Optimization
  • 7.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.6. Predictive Analytics
  • 7.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.7. Clinical Decision Support
  • 7.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.8. Others
  • 7.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. AI in Radiology Market: End Use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global AI in Radiology Market End Use Movement Analysis
• 8.3. Global AI in Radiology Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 8.4. Hospitals
  • 8.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 8.5. Clinics
  • 8.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 8.6. Diagnostic Imaging Centers
  • 8.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 8.7. Research and Academic Institutions
  • 8.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 8.8. Others
  • 8.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 9. AI in Radiology Market: Regional Estimates & Trend Analysis

• 9.1. Regional Market Share Analysis, 2025 & 2033
• 9.2. Regional Market Dashboard
• 9.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
• 9.4. North America
  • 9.4.1. U.S.
    • 9.4.1.1. Key country dynamics
    • 9.4.1.2. Regulatory framework
    • 9.4.1.3. Competitive scenario
    • 9.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.4.2. Canada
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Regulatory framework
    • 9.4.2.3. Competitive scenario
    • 9.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.4.3. Mexico
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Regulatory framework
    • 9.4.3.3. Competitive scenario
    • 9.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
• 9.5. Europe
  • 9.5.1. UK
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Regulatory framework
    • 9.5.1.3. Competitive scenario
    • 9.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.5.2. Germany
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.5.3. France
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework
    • 9.5.3.3. Competitive scenario
    • 9.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.5.4. Italy
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Regulatory framework
    • 9.5.4.3. Competitive scenario
    • 9.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.5.5. Spain
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Regulatory framework
    • 9.5.5.3. Competitive scenario
    • 9.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.5.6. Norway
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Regulatory framework
    • 9.5.6.3. Competitive scenario
    • 9.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.5.7. Sweden
    • 9.5.7.1. Key country dynamics
    • 9.5.7.2. Regulatory framework
    • 9.5.7.3. Competitive scenario
    • 9.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.5.8. Denmark
    • 9.5.8.1. Key country dynamics
    • 9.5.8.2. Regulatory framework
    • 9.5.8.3. Competitive scenario
    • 9.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
• 9.6. Asia Pacific
  • 9.6.1. Japan
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Regulatory framework
    • 9.6.1.3. Competitive scenario
    • 9.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.6.2. China
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.6.3. India
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Regulatory framework
    • 9.6.3.3. Competitive scenario
    • 9.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.6.4. Australia
    • 9.6.4.1. Key country dynamics
    • 9.6.4.2. Regulatory framework
    • 9.6.4.3. Competitive scenario
    • 9.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.6.5. South Korea
    • 9.6.5.1. Key country dynamics
    • 9.6.5.2. Regulatory framework
    • 9.6.5.3. Competitive scenario
    • 9.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.6.6. Thailand
    • 9.6.6.1. Key country dynamics
    • 9.6.6.2. Regulatory framework
    • 9.6.6.3. Competitive scenario
    • 9.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
• 9.7. Latin America
  • 9.7.1. Brazil
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Regulatory framework
    • 9.7.1.3. Competitive scenario
    • 9.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.7.2. Argentina
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
• 9.8. MEA
  • 9.8.1. South Africa
    • 9.8.1.1. Key country dynamics
    • 9.8.1.2. Regulatory framework
    • 9.8.1.3. Competitive scenario
    • 9.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.8.2. Saudi Arabia
    • 9.8.2.1. Key country dynamics
    • 9.8.2.2. Regulatory framework
    • 9.8.2.3. Competitive scenario
    • 9.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.8.3. UAE
    • 9.8.3.1. Key country dynamics
    • 9.8.3.2. Regulatory framework
    • 9.8.3.3. Competitive scenario
    • 9.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.8.4. Kuwait
    • 9.8.4.1. Key country dynamics
    • 9.8.4.2. Regulatory framework
    • 9.8.4.3. Competitive scenario
    • 9.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Company/Competition Categorization
• 10.2. Strategy Mapping
• 10.3. Company Market Position Analysis, 2025
• 10.4. Company Profiles/Listing
  • 10.4.1. Siemens Healthineers AG
    • 10.4.1.1. Company overview
    • 10.4.1.2. Financial performance
    • 10.4.1.3. Product benchmarking
    • 10.4.1.4. Strategic initiatives
  • 10.4.2. GE HealthCare
    • 10.4.2.1. Company overview
    • 10.4.2.2. Financial performance
    • 10.4.2.3. Product benchmarking
    • 10.4.2.4. Strategic initiatives
  • 10.4.3. Koninklijke Philips N.V.
    • 10.4.3.1. Company overview
    • 10.4.3.2. Financial performance
    • 10.4.3.3. Product benchmarking
    • 10.4.3.4. Strategic initiatives
  • 10.4.4. Canon Medical Systems
    • 10.4.4.1. Company overview
    • 10.4.4.2. Financial performance
    • 10.4.4.3. Product benchmarking
    • 10.4.4.4. Strategic initiatives
  • 10.4.5. Fujifilm Holdings Corporation
    • 10.4.5.1. Company overview
    • 10.4.5.2. Financial performance
    • 10.4.5.3. Product benchmarking
    • 10.4.5.4. Strategic initiatives
  • 10.4.6. Aidoc
    • 10.4.6.1. Company overview
    • 10.4.6.2. Financial performance
    • 10.4.6.3. Product benchmarking
    • 10.4.6.4. Strategic initiatives
  • 10.4.7. Tempus AI
    • 10.4.7.1. Company overview
    • 10.4.7.2. Financial performance
    • 10.4.7.3. Product benchmarking
    • 10.4.7.4. Strategic initiatives
  • 10.4.8. Lunit
    • 10.4.8.1. Company overview
    • 10.4.8.2. Financial performance
    • 10.4.8.3. Product benchmarking
    • 10.4.8.4. Strategic initiatives
  • 10.4.9. Viz.ai
    • 10.4.9.1. Company overview
    • 10.4.9.2. Financial performance
    • 10.4.9.3. Product benchmarking
    • 10.4.9.4. Strategic initiatives
  • 10.4.10. Riverain Technologies
    • 10.4.10.1. Company overview
    • 10.4.10.2. Financial performance
    • 10.4.10.3. Product benchmarking
    • 10.4.10.4. Strategic initiatives
  • 10.4.11. Qure.ai
    • 10.4.11.1. Company overview
    • 10.4.11.2. Financial performance
    • 10.4.11.3. Product benchmarking
    • 10.4.11.4. Strategic initiatives
  • 10.4.12. Infervision
    • 10.4.12.1. Company overview
    • 10.4.12.2. Financial performance
    • 10.4.12.3. Product benchmarking
    • 10.4.12.4. Strategic initiatives